FindTrial
Sign In

Role of Vitamin D and Magnesium in Patients with Breathing Problem Attacks.

The Role of Vitamin D3 and Magnesium in Patients with Acute Exacerbation of Obstructive Airway Disease (OAD). - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/04/109211
Enrollment
94
Registered
2026-04-23
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J441- Chronic obstructive pulmonary disease with (acute) exacerbation

Interventions

Intervention1: Nil: Nil

Sponsors

Datta Meghe Institute of Higher Education and Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Age more than 18 years. 2.A known case of or a newly diagnosed case of OAD; including asthma, COPD and bronchiectasis, hospitalised for acute exacerbation (defined by more than or equal to 2 key symptoms worsening).

Exclusion criteria

Exclusion criteria: 1.Immunocompromised status 2.Active lung malignancy or other malignancy 3.Pregnant or lactating women 4.Patients with underlying dyselectrolytemia 5.Current magnesium/vitamin D supplementation

Design outcomes

Primary

MeasureTime frame
Serum Vitamin D3 levels (ng/mL) Serum Magnesium levels (mg/dL)Timepoint: At admission, Day 1—

Secondary

MeasureTime frame
Correlation between deficiency levels & exacerbation severity (based on clinical, spirometric, & radiological findings)Timepoint: At admission, Day 1—

Countries

India

Contacts

Public ContactDr Soni Amisha Harish

Datta Meghe Institute of Higher Education and Research

crownbabaji@gmail.com09822342770

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026